BRVE logo

Braveheart Bio, Inc.

BRVE
Healthcare|Biotechnology|US
$18.60
+1.19 (+6.80%)
Next Earnings Report
Dec 8, 2026
EPS est. -$0.44
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest Aug 6, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (1)

Oct 2028
Est. completion
P3Cardiomyopathy, Hypertrophic Obstructive
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT07755904n=210

Recent Press Releases

Hengrui Pharma and Braveheart Bio Present Data from 52-Week Open-Label Extension of Phase 2 Study of HRS/BHB-1893 in Obstructive Hypertrophic Cardiomyopathy at American Heart Association Scientific Sessions 2026
Nov 6, 2026 · GlobeNewsWire
Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026
Oct 30, 2026 · GlobeNewsWire
Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026
Oct 30, 2026 · GlobeNewsWire
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
Sep 16, 2026 · GlobeNewsWire
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
Sep 8, 2026 · GlobeNewsWire
Braveheart Bio to Participate in Cantor Global Healthcare Conference
Sep 1, 2026 · GlobeNewsWire

SEC Filings (19)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Nov 5, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 10, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Sep 8, 202610-QQuarterly reportDocumentIndex
Sep 8, 20268-KMaterial eventDocumentIndex
Aug 18, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 14, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 7, 20268-KMaterial eventDocumentIndex
Aug 6, 2026S-8Employee stock planDocumentIndex
Aug 6, 2026424B4Offering prospectusDocumentIndex
Aug 6, 2026CERTDocumentIndex
Aug 5, 2026EFFECTDocumentIndex
Aug 5, 2026S-1MEFIPO / offering registrationDocumentIndex
Aug 3, 20268-A12BDocumentIndex
Jul 30, 2026S-1/AIPO / offering registrationDocumentIndex
Jul 15, 2026S-1IPO / offering registrationDocumentIndex
Jun 8, 2026DRS/ADocumentIndex
Apr 29, 2026DRSDocumentIndex